tabilautide

{{Chembox

| ImageFile = Tabilautide.svg

| ImageSize = 250px

| ImageAlt =

| IUPACName = (2S,6S)-6-Amino-6-carbamoyl-2-[(4R)-4-carboxy-4-[(2R)-2-dodecanamidopropanamido]butanamido]hexanoic acid

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo1 = 78088-46-7

| CASNo1_Ref = {{Cascite|changed|CAS}}

| index1_label = (unspecified stereochemistry)

| ChEMBL = 3989637

| SMILES = CCCCCCCCCCCC(=O)N[C@H](C)C(=O)N[C@H](CCC(=O)N[C@@H](CCC[C@H](N)C(N)=O)C(O)=O)C(O)=O

| PubChem = 3086083

| UNII = EZ61NB05TG

| ChemSpiderID = 2342790

| StdInChI = 1S/C27H49N5O8/c1-3-4-5-6-7-8-9-10-11-15-22(33)30-18(2)25(36)32-21(27(39)40)16-17-23(34)31-20(26(37)38)14-12-13-19(28)24(29)35/h18-21H,3-17,28H2,1-2H3,(H2,29,35)(H,30,33)(H,31,34)(H,32,36)(H,37,38)(H,39,40)/t18-,19-,20-,21+/m0/s1

| StdInChIKey = TUNXCNXMSJZNPO-XSDIEEQYSA-N}}

|Section2={{Chembox Properties

| C=27 | H=49 | N=5 | O=8

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Tabilautide is an immunological agent. It was studied as a potential drug for the treatment of cancer, but development for this purpose has been discontinued.{{cite web | url = https://adisinsight.springer.com/drugs/800000836 | title = Tabilautide | work = Adis Insight }}